Ironwood Pharmaceuticals Inc Financial Flexibility Index
Ironwood Pharmaceuticals Inc financial flexibility index. Ironwood Pharmaceuticals Inc (IRWD) has a Financial Flexibility Index of 0.13x as of June 2026. Free cash flow of $58.28 Million (operating CF $58.28 Million minus capex $0.00) represents 0% of total liabilities ($446.97 Million). See Ironwood Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ironwood Pharmaceuticals Inc (2007–2025)
Financial flexibility index of Ironwood Pharmaceuticals Inc from 2007 to 2025. Historical Financial Flexibility Index trend for Ironwood Pharmaceuticals Inc across 19 annual periods. Check cash flow quality index of Ironwood Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
Ironwood Pharmaceuticals Inc Financial Flexibility Index by Year (2007–2025)
Ironwood Pharmaceuticals Inc financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Ironwood Pharmaceuticals Inc. For the full cash flow conversion analysis, see Ironwood Pharmaceuticals Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $127.08 Million | $127.04 Million | $658.74 Million | ▲ +21.3% |
| 2024 | 0.16x | $103.69 Million | $103.55 Million | $652.24 Million | ▼ -29.3% |
| 2023 | 0.22x | $183.70 Million | $183.43 Million | $817.37 Million | ▼ -63.2% |
| 2022 | 0.61x | $273.90 Million | $273.76 Million | $448.14 Million | ▲ +21.5% |
| 2021 | 0.50x | $262.16 Million | $261.89 Million | $521.02 Million | ▲ +46.4% |
| 2020 | 0.34x | $170.68 Million | $168.84 Million | $496.60 Million | ▲ +851.6% |
| 2019 | 0.04x | $17.91 Million | $10.72 Million | $496.00 Million | ▲ +130.7% |
| 2018 | -0.12x | $-62.26 Million | $-70.88 Million | $528.42 Million | ▲ +26.4% |
| 2017 | -0.16x | $-95.35 Million | $-99.56 Million | $595.83 Million | ▼ -230.7% |
| 2016 | 0.12x | $78.77 Million | $-25.43 Million | $643.11 Million | ▲ +162.4% |
| 2015 | -0.20x | $-102.88 Million | $-106.93 Million | $524.00 Million | ▲ +68.4% |
| 2014 | -0.62x | $-152.03 Million | $-155.57 Million | $244.96 Million | ▲ +43.4% |
| 2013 | -1.10x | $-263.76 Million | $-273.36 Million | $240.74 Million | ▼ -69.0% |
| 2012 | -0.65x | $-55.65 Million | $-69.63 Million | $85.86 Million | ▲ +2.0% |
| 2011 | -0.66x | $-65.56 Million | $-75.24 Million | $99.12 Million | ▼ -85.1% |
| 2010 | -0.36x | $-50.68 Million | $-67.90 Million | $141.81 Million | ▼ -350460.4% |
| 2009 | 0.00x | $47.00K | $-4.00 Million | $460.79 Million | ▲ +100.7% |
| 2008 | -0.01x | $-5.26 Million | $-28.20 Million | $371.13 Million | ▼ -8.4% |
| 2007 | -0.01x | $-4.11 Million | $-6.76 Million | $314.28 Million | — |